Exagen Inc.XGNNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank33
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-14.27M
↑ 11% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-16.08M
Historical baseline
PeriodValueYoY Change
TTM$-14.27M-3.4%
2024$-13.79M+9.8%
2023$-15.29M+58.1%
2022$-36.46M-61.1%
2021$-22.64M-55.7%
2020$-14.54M-43.8%
2019$-10.11M-6.5%
2018$-9.50M+17.6%
2017$-11.54M+9.2%
2015$-12.71M-